DD13769A - - Google Patents
Info
- Publication number
- DD13769A DD13769A DD13769DA DD13769A DD 13769 A DD13769 A DD 13769A DD 13769D A DD13769D A DD 13769DA DD 13769 A DD13769 A DD 13769A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD13769A true DD13769A (en) |
Family
ID=225646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD13769D DD13769A (en) |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD13769A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104662007B (en) * | 2012-07-25 | 2018-03-16 | 索瓦制药公司 | Cystathionine gamma lyase (CSE) inhibitor |
-
0
- DD DD13769D patent/DD13769A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104662007B (en) * | 2012-07-25 | 2018-03-16 | 索瓦制药公司 | Cystathionine gamma lyase (CSE) inhibitor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018200632B2 (en) | Cystathionine-y-lyase (CSE) inhibitors | |
| JP2015524807A5 (en) | ||
| CN106029641B (en) | 1,1- bis- substitutes the manufacture method of hydrazine compound | |
| US11021501B2 (en) | Creatine phosphate analog prodrugs, compositions and methods of use thereof | |
| US9504655B2 (en) | Capsule dosage form of metoprolol succinate | |
| WO2020247819A2 (en) | Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulators | |
| DD13769A (en) |